Today: 9 June 2026
Bath & Body Works stock jumps 5% as BBWI rebounds despite fresh class-action deadline
30 January 2026
1 min read

Bath & Body Works stock jumps 5% as BBWI rebounds despite fresh class-action deadline

NEW YORK, Jan 30, 2026, 15:43 EST — Regular session

Bath & Body Works shares (BBWI) climbed 5.3% to $21.83 during Friday’s afternoon session. The stock fluctuated between $20.38 and $21.99, with roughly 3.4 million shares traded.

U.S. stocks edged higher in a volatile session after Donald Trump nominated Kevin Warsh to succeed Jerome Powell as Federal Reserve chair when Powell’s term ends in May. Investors grappled with a mix of earnings reports and inflation data. “There’s a combination of investor concerns around the Fed chair announcement, some mixed tech earnings and lingering inflation pressure,” said Angelo Kourkafas, senior global strategist at Edward Jones. Reuters

Traders watching Bath & Body Works have spotted a series of law-firm alerts linked to a securities fraud class action. The Schall Law Firm announced that investors who purchased shares between June 4, 2024, and Nov. 19, 2025, can try to become “lead plaintiff” by March 16. This lead plaintiff would have the authority to guide the lawsuit if a judge certifies it as a class action. According to the firm, the complaint claims the retailer misled investors about whether collaborations and promotions were driving sustainable growth, citing alleged breaches of SEC rules. PR Newswire

Shares in beauty and personal care showed varied moves: Ulta Beauty climbed roughly 1.5%, Estée Lauder barely budged, and Coty inched up.

The legal headlines come after a tough period for the retailer. In November, Bath & Body Works shocked with a holiday quarter sales dip, lowered its full-year guidance, and unveiled a transformation plan aiming to save $250 million over two years. The stock plunged almost 24% that same day.

Friday’s rally gave the shares a boost, but it doesn’t solve the bigger question investors keep asking: how much demand is simply being pulled forward through promotions, and what impact that will have on margins.

But the legal overhang brings its own risks. Securities cases often drag on for months, with mounting costs and management distraction becoming issues long before any court decision.

Investors are watching the broader market closely. Shifts in rate expectations, inflation data, and earnings volatility have been driving sharp moves in consumer stocks, often with little fresh news from the companies themselves.

March 16 marks the deadline for investors to submit their requests to be named lead plaintiff. This decision can significantly influence the pace and intensity of the case moving forward.

Stock Market Today

  • The Oncology Institute (TOI) Shares Show 38.1% Upside According to Wall Street Analysts
    June 9, 2026, 11:45 AM EDT. Shares of The Oncology Institute, Inc. (TOI) have risen 26.4% in the last four weeks, closing at $5.07. Wall Street analysts set a mean short-term price target of $7, suggesting a potential upside of 38.1%. Targets range from $5.00 to $8.00, reflecting some variability with a standard deviation of $1.41, indicating mixed analyst views. Despite caution over historically optimistic analyst estimates-sometimes influenced by firm relationships-consensus earnings revisions also signal possible stock gains. While analyst price targets offer a snapshot of market sentiment, investors are advised to consider them as part of broader research rather than sole investment criteria.

Latest articles

Coupang Stock Gains as Privacy Ruling Approaches

Coupang Stock Gains as Privacy Ruling Approaches

9 June 2026
Coupang shares jumped 2% to $15.49, outperforming a falling market, as investors braced for South Korea’s privacy regulator to decide June 10 on possible sanctions over a data breach exposing 33.6 million records—a ruling that could trigger fines up to 3% of sales and impact the stock’s recovery.
AEP’s $78 Billion Grid Plan Spurs Data Center Hopes

AEP’s $78 Billion Grid Plan Spurs Data Center Hopes

9 June 2026
AEP lifted its five-year capital plan to $78 billion after signing 7 gigawatts of new large-energy project agreements, with 90% of 63 gigawatts of expected incremental load by 2030 tied to data centers; shares recently traded at $127.27, up 26.9% over 52 weeks, with analysts’ mean price target at $142.76, as investors weigh execution risks and a new data-center rate structure.
Dow climbs in New York, but gains may stall

Dow climbs in New York, but gains may stall

9 June 2026
Dow jumps 154.87 points as tech rebounds and oil prices drop, with chipmakers like Intel and Broadcom up sharply; investors brace for Wednesday’s key inflation data and next week’s Fed meeting, which could sway rate expectations and market direction.
U.S. Stocks Hit Records This Week — Why the S&P 500 and Nasdaq Rally Survived the Oil Shock

Dow Up While Nasdaq Dips; AI Rally Meets Inflation Data

9 June 2026
Nuvalent soared after GSK agreed to buy the cancer drug developer for $10.6 billion in cash, valuing shares at $124—a 40% premium to Monday’s close—while investors awaited Wednesday’s key inflation data that could impact market direction and tech stock stability.
Smart Logistics Jumps 159% Before Nasdaq Halt

Smart Logistics Jumps 159% Before Nasdaq Halt

9 June 2026
Smart Logistics Global soared 158.75% to $1.33 before a Nasdaq volatility pause, putting the stock above the $1 minimum bid-price needed for compliance after months below the threshold; the company must now close at or above $1 for 10 straight business days to avoid further Nasdaq action, with no new company news driving the surge.
Joby Aviation stock drops again as $1.2 billion capital raise puts dilution back in focus
Previous Story

Joby Aviation stock drops again as $1.2 billion capital raise puts dilution back in focus

Oracle stock price drops again as AI fears weigh; Air Force cloud order lands
Next Story

Oracle stock price drops again as AI fears weigh; Air Force cloud order lands

Go toTop